Retrospective Analysis for Patients With Metabolic Syndrome

Zhejiang University

Status: Enrolling

Conditions: Metabolic Syndrome

Treatments: Other: dietary, semaglutide or/and metformin

Study type: Observational

Funder types: Other

Identifiers

NCT06182618

2023-1042

Details and patient eligibility

About

The incidence of metabolic syndrome and related diseases is gradually increasing, and diet and medication are currently common outpatient treatment methods. This study retrospectively analyzes the clinical data of patients with metabolic syndrome and related diseases who have visited our outpatient department in the past 10 years, compares the therapeutic effects of different treatment methods on their blood glucose, blood lipids, blood pressure, uric acid, and body composition, and provides evidence support for clinical treatment.

Enrollment: 400 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• individuals who had at least a 2 follow up visits with a BMI of 24 or more with the pri-mary goal of losing weight.

Exclusion criteria

• patients did not follow-up on a monthly basis;
• patients followed-up less than 1 times within 3 months;
• patients having incomplete data;
• patients changing their interventions during fol-low-ups

Trial design

400 participants in 3 patient groups

low-carbohydrate diet

Description:

20-30% carbohydrates, 40-45%fat, and 30-40%protein

Treatment:

Other: dietary, semaglutide or/and metformin

balanced diet

Description:

50-65% carbohydrate, 20-30% fat and 10-20% protein

Treatment:

Other: dietary, semaglutide or/and metformin

pharmacotherapy

Description:

semaglutide (1mg per week) or/and metformin (o.5g three times a day)

Treatment:

Other: dietary, semaglutide or/and metformin